AI News

AIN

Takeda signs US$600M AI drug discovery deal with Insilico

Takeda has entered a strategic collaboration with Hong Kong-based Insilico Medicine to use AI in early-stage drug discovery across the Japanese pharmaceutical company’s therapeutic areas. The companies did not disclose which therapeutic areas or disease targets will be covered under the collaboration. The agreement gives Takeda access to Insilico’s Pharma.AI platform, which supports biological target […] The post Takeda signs US$600M AI drug discovery deal with Insilico appeared first on A

Takeda Insilico Medicine AI drug discovery
32

OpenAI Plans to Donate 5% Equity to US Government: A New Game Between AI Giant and Political Power

OpenAI is in deep discussions with the Trump administration to donate approximately 5% of its equity, valued between $42 billion and $43 billion, to a US sovereign wealth fund, aiming to share AI profits while addressing political and regulatory concerns. CEO Sam Altman has suggested this model could expand to other AI firms, sparking widespread debate on X platform.

OpenAI 股权捐赠 特朗普政府
114

Anthropic Relaunches Claude Fable 5 with New Cybersecurity Restrictions, Global Launch on July 2, 2026

On July 1, 2026, Anthropic announced that Claude Fable 5 will go live globally the next day. Previously suspended due to U.S. export controls, the model now includes a classifier to block cybersecurity-related tasks, with routine coding and debugging falling back to Opus 4.8. It also initiates the Glasswing framework with Amazon, Microsoft, and Google to assess the severity of AI jailbreaks, and strengthens model testing collaboration with the U.S. government.

Anthropic Claude Fable 5 AI Safety
281